Scholar Rock Holding Corporation
SRRK
Xếp hạng trong cổ phiếu
#3308
Scholar Rock Holding Corporation is a biopharmaceutical firm dedicated to... Scholar Rock Holding Corporation is a biopharmaceutical firm dedicated to discovering and advancing treatments for severe medical conditions by targeting the crucial role of protein growth factor signaling. Their lead therapeutic candidate, Apitegromab, an agent designed to inhibit the activation of latent myostatin, has successfully concluded Phase 3 clinical trials for spinal muscular atrophy (SMA). Another key program, SRK-181, is currently undergoing Phase 1 clinical assessment for tackling cancers that exhibit resistance to established checkpoint inhibitor treatments, including anti-PD-1 or anti-PD-L1 antibody therapies. Beyond these, the company cultivates a robust pipeline of innovative potential therapies, aiming to significantly improve the lives of individuals grappling with various severe ailments, such as neurological muscle conditions, malignancies, and fibrotic disorders. In a strategic partnership, Scholar Rock is collaborating with Gilead Sciences, Inc. to identify and develop targeted inhibitors of transforming growth factor beta (TGF-beta) activation, specifically for addressing fibrotic diseases. Established in 2012, Scholar Rock Holding Corporation operates from its headquarters in Cambridge, Massachusetts.
Giá cổ phiếu
$43.16
Đồng bộ lần cuối: 2026-10-21
Vốn hóa thị trường
$5.26B
Thay đổi (1 ngày)
4.35%
Thay đổi (1 năm)
51.33%
Quốc gia
US
Giao dịch Scholar Rock Holding Corporation (SRRK)
Danh mục
Healthcare
Lịch sử giá cổ phiếu của Scholar Rock Holding Corporation (SRRK)
Giá đóng cửa cao nhất: $42.18 vào 2026-10-01
Giá đóng cửa thấp nhất: $16.12 vào 2018-05-01
Giá đóng cửa thấp nhất: $16.12 vào 2018-05-01
Lịch sử giá cổ phiếu của Scholar Rock Holding Corporation từ 2018 đến 2026
Hiệu suất giá cổ phiếu hàng năm
| Năm | Hiệu suất |
|---|---|
| 2026 (TTM) | 3.69% |
| 2025 | 4.21% |
| 2024 | 139.27% |
| 2023 | 123.69% |
| 2022 | -68.52% |
| 2021 | -46.82% |
| 2020 | 347.42% |
| 2019 | -54.48% |
| 2018 | 0.00% |
Giá cổ phiếu của các công ty hoặc đối thủ tương tự
| Công ty | Giá cổ phiếu | Thay đổi 1năm% | Quốc gia |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $766.95 | 9.01% |
CH
|
